Principal Financial Group
NUVB icon

Principal Financial Group’s Nuvation Bio NUVB Stock Holding History

Principal Financial Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109K Buy
19,272
+8,042
+72% +$39.3K ﹤0.01% 2110
2026
Q1 		$48.2K Buy
11,230
+531
+5% +$2.96K ﹤0.01% 2153
2025
Q4 		$95.9K Sell
10,699
-6,915
-39% -$42.8K ﹤0.01% 2149
2025
Q3 		$65.2K Buy
17,614
+473
+3% +$1.29K ﹤0.01% 2203
2025
Q2 		$33.4K Buy
17,141
+5,383
+46% +$11.2K ﹤0.01% 2202
2025
Q1 		$20.7K Buy
11,758
+1,619
+16% +$3.69K ﹤0.01% 2146
2024
Q4 		$27K Sell
10,139
-2,363
-19% -$6.08K ﹤0.01% 2189
2024
Q3 		$28.6K Sell
12,502
-13,448
-52% -$41K ﹤0.01% 2202
2024
Q2 		$75.8K Buy
25,950
+9,603
+59% +$29.3K ﹤0.01% 2244
2024
Q1 		$59.5K Sell
16,347
-1,198
-7% -$2.3K ﹤0.01% 2330
2023
Q4 		$26.5K Sell
17,545
-2,906
-14% -$3.74K ﹤0.01% 2375
2023
Q3 		$27.4K Buy
20,451
+4,983
+32% +$8.29K ﹤0.01% 2390
2023
Q2 		$27.8K Sell
15,468
-33,245
-68% -$56.5K ﹤0.01% 2399
2023
Q1 		$80.9K Buy
48,713
+3,500
+8% +$7.09K ﹤0.01% 2328
2022
Q4 		$86.8K Buy
45,213
+8,296
+22% +$16.8K ﹤0.01% 2319
2022
Q3 		$82K Buy
36,917
+6,395
+21% +$18.3K ﹤0.01% 2364
2022
Q2 		$99K Sell
30,522
-20,537
-40% -$89.6K ﹤0.01% 2393
2022
Q1 		$268K Buy
51,059
+181
+0.4% +$1.02K ﹤0.01% 2267
2021
Q4 		$433K Buy
50,878
+38,208
+302% +$351K ﹤0.01% 2160
2021
Q3 		$126K Buy
+12,670
New +$115K ﹤0.01% 2480

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Principal Financial Group's NUVB Position: Q2 2026 in Review

Principal Financial Group increased its Nuvation Bio (NUVB) stake by 72% in Q2 2026, buying an estimated $39.3K and bringing the position to 19,272 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #2110.

Principal Financial Group first reported a position in NUVB in Q3 2021 and has held it in 20 quarters since. The position peaked at $433K in Q4 2021. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Principal Financial Group held 19,272 shares of Nuvation Bio worth $109K as of Q2 2026.
  • Principal Financial Group bought 8,042 Nuvation Bio shares in Q2 2026, an estimated $39.3K.
  • Nuvation Bio made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #2110 holding.
  • Principal Financial Group first reported a position in Nuvation Bio in Q3 2021 and has held it in 20 quarters since.
  • Principal Financial Group's Nuvation Bio position peaked at $433K in Q4 2021.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.